AAAAAA
Results:
1-13
|
Results: 13
Authors:
Nickel, P
Lacha, J
Ode-Hakim, S
Sawitzki, B
Babel, N
Frei, U
Volk, HD
Reinke, P
Citation: P. Nickel et al., Cytotoxic effector molecule gene expression in acute renal allograft rejection - Correlation with clinical outcome; histopathology and function of the allograft, TRANSPLANT, 72(6), 2001, pp. 1158-1161
Authors:
Braun, K
Rettinger, J
Ganso, M
Kassack, M
Hildebrandt, C
Ullmann, H
Nickel, P
Schmalzing, G
Lambrecht, G
Citation: K. Braun et al., NF449: a subnanomolar potency antagonist at recombinant rat P2X(1) receptors, N-S ARCH PH, 364(3), 2001, pp. 285-290
Authors:
Dhar, S
Gullbo, J
Csoka, K
Eriksson, E
Nilsson, K
Nickel, P
Larsson, R
Nygren, P
Citation: S. Dhar et al., Antitumour activity of suramin analogues in human tumour cell lines and primary cultures of tumour cells from patients, EUR J CANC, 36(6), 2000, pp. 803-809
Authors:
Firsching-Hauck, A
Nickel, P
Yahya, C
Wandt, C
Kulik, R
Simon, N
Zink, M
Nehls, V
Allolio, B
Citation: A. Firsching-hauck et al., Angiostatic effects of suramin analogs in vitro, ANTI-CANC D, 11(2), 2000, pp. 69-77
Authors:
Rettinger, J
Schmalzing, G
Damer, S
Muller, G
Nickel, P
Lambrecht, G
Citation: J. Rettinger et al., The suramin analogue NF279 is a novel and potent antagonist selective for the P2X(1) receptor, NEUROPHARM, 39(11), 2000, pp. 2044-2053
Authors:
Klapperstuck, M
Buttner, C
Nickel, P
Schmalzing, G
Lambrecht, G
Markwardt, F
Citation: M. Klapperstuck et al., Antagonism by the suramin analogue NF279 on human P2X(1) and P2X(7) receptors, EUR J PHARM, 387(3), 2000, pp. 245-252
Authors:
Camerman, A
Mastropaolo, D
Nickel, P
Hempel, A
Camerman, N
Citation: A. Camerman et al., Structure of 8-[4 '-(3 ''-nitrobenzamido)benzamido]naphthalene-1,3,6-trisulfonate (NF-033), and molecular basis of its cellular toxicity, CAN J CHEM, 78(1), 2000, pp. 26-30
Authors:
Sneddon, P
Westfall, TD
Todorov, LD
Todorova, SM
Westfall, DP
Nickel, P
Kennedy, C
Citation: P. Sneddon et al., The effect of P2 receptor antagonists and ATPase inhibition on sympatheticpurinergic neurotransmission in the guinea-pig isolated vas deferens, BR J PHARM, 129(6), 2000, pp. 1089-1094
Authors:
Lambrecht, G
Damer, S
Niebel, B
Czeche, S
Nickel, P
Rettinger, J
Schmalzing, G
Mutschler, E
Citation: G. Lambrecht et al., Novel ligands for P2 receptor subtypes in innervated tissues, PROG BRAIN, 120, 1999, pp. 107-117
Authors:
Soto, F
Lambrecht, G
Nickel, P
Stuhmer, W
Busch, AE
Citation: F. Soto et al., Antagonistic properties of the suramin analogue NF023 at heterologously expressed P2X receptors, NEUROPHARM, 38(1), 1999, pp. 141-149
Authors:
Klinger, M
Freissmuth, M
Nickel, P
Stabler-Schwarzbart, M
Kassack, M
Suko, J
Hohenegger, M
Citation: M. Klinger et al., Suramin and suramin analogs activate skeletal muscle ryanodine receptor via a calmodulin binding site, MOLEC PHARM, 55(3), 1999, pp. 462-472
Authors:
Nickel, P
Nachreiner, F
Zdobych, A
Yanagibori, R
Citation: P. Nickel et al., Evaluation of mental workload via the 0.1 Hz component of heartrate variability - some methodological and technical problems., Z ARB ORGAN, 42(4), 1998, pp. 205-212
Authors:
Zlotos, G
Oehlmann, M
Nickel, P
Holzgrabe, U
Citation: G. Zlotos et al., Determination of protein binding of gyrase inhibitors by means of continuous ultrafiltration, J PHARM B, 18(4-5), 1998, pp. 847-858
Risultati:
1-13
|